全文获取类型
收费全文 | 11707篇 |
免费 | 865篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 396篇 |
妇产科学 | 237篇 |
基础医学 | 1425篇 |
口腔科学 | 202篇 |
临床医学 | 1123篇 |
内科学 | 2418篇 |
皮肤病学 | 245篇 |
神经病学 | 1004篇 |
特种医学 | 544篇 |
外科学 | 1692篇 |
综合类 | 166篇 |
一般理论 | 6篇 |
预防医学 | 1145篇 |
眼科学 | 255篇 |
药学 | 625篇 |
中国医学 | 7篇 |
肿瘤学 | 941篇 |
出版年
2022年 | 90篇 |
2021年 | 216篇 |
2020年 | 130篇 |
2019年 | 194篇 |
2018年 | 233篇 |
2017年 | 176篇 |
2016年 | 172篇 |
2015年 | 200篇 |
2014年 | 268篇 |
2013年 | 434篇 |
2012年 | 695篇 |
2011年 | 719篇 |
2010年 | 372篇 |
2009年 | 344篇 |
2008年 | 603篇 |
2007年 | 658篇 |
2006年 | 620篇 |
2005年 | 595篇 |
2004年 | 555篇 |
2003年 | 493篇 |
2002年 | 456篇 |
2001年 | 251篇 |
2000年 | 232篇 |
1999年 | 220篇 |
1998年 | 129篇 |
1997年 | 86篇 |
1996年 | 82篇 |
1995年 | 80篇 |
1994年 | 80篇 |
1993年 | 83篇 |
1992年 | 179篇 |
1991年 | 157篇 |
1990年 | 150篇 |
1989年 | 167篇 |
1988年 | 158篇 |
1987年 | 160篇 |
1986年 | 175篇 |
1985年 | 174篇 |
1984年 | 119篇 |
1983年 | 122篇 |
1982年 | 72篇 |
1981年 | 76篇 |
1980年 | 88篇 |
1979年 | 121篇 |
1978年 | 87篇 |
1977年 | 86篇 |
1975年 | 71篇 |
1974年 | 72篇 |
1973年 | 84篇 |
1972年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Joe Jacob Shibhu George B. R. Suchit Roy P. U. Rajesh 《Indian journal of otolaryngology and head and neck surgery》2006,58(1):76-77
Malignancy larynx usually presents early, the common symptoms being hoarseness, pain thorat, cough and irritation of throat. An advanced malignancy is likely to be complicated by a pharyngo-cutaneous fistula. However it is an occurrence towards the end stage of the disease. Here we present a case of malignancy larynx primarily presenting as pharyngo-cutaneous fistula without any other symptoms. 相似文献
4.
5.
Joe Matsumoto Tetsufumi Kojima Tetsuya Shimizu Shuji Kitashiro Kazuya Konishi Yoshiyuki Matsumura You Kawarada Hitoshi Ikeda Takashi Yoshiki 《Annals of thoracic and cardiovascular surgery》2002,8(3):151-153
In lung cancer patients, hypercalcemia is a fairly common metabolic problem associated with malignancy. However, the occurrence of hypercalcemia in lung cancer patients means an ominous prognostic sign. As hypercalcemia often causes early death, quick diagnosis and treatment for hypercalcemia are required. A 69-year-old woman was admitted to our hospital with anorexia caused by hypercalcemia. On admission, serum level of PTH was elevated and PTHrP was normal. From the results of CT findings and transbronchial lung biopsy, the cause of the hypercalcemia was determined as lung cancer incidentally complicated with primary hyperparathyroidism. First, serum calcium level was returned to normal through hydration with saline and bisphosphonates. Next, left hemithyroidectomy for primary hyperparathyroidism was performed. Histologically, the tumor was diagnosed as parathyroid adenoma. Fifteen days later, left lower lobectomy for primary lung cancer was performed under a video-assisted thoracoscopic approach. Histologically, the tumor was diagnosed as a moderately differentiated adenocarcinoma. Four years and three months after the operation, the patient is alive and well with no sign of recurrence. When a lung cancer patient is complicated with hypercalcemia, we need to consider that primary hyperparathyroidism is a possible cause of the hypercalcemia. 相似文献
6.
Williamson Kathleen A.; Hever Ann M.; Rainger Joe; Rogers R. Curtis; Magee Alex; Fiedler Zdenek; Keng Wee Teik; Sharkey Freddie H.; McGill Niolette; Hill Clare J.; Schneider Adele; Messina Mario; Turnpenny Peter D.; Fantes Judy A.; van Heyningen Veronica; FitzPatrick David R. 《Human molecular genetics》2006,15(12):2030
Table 1 相似文献
7.
K A Rosenthal 《Dimensions of critical care nursing》1989,8(5):310-316
The information in this article is for a wide variety of nurses who find themselves in a teaching role: the critical care nurse orienting another nurse (experienced or new graduate); the critical care manager who needs to present an inservice program; and the educator or clinical specialist looking for a new way to present the same information. The author describes how self-paced modules for inservice education offer variety to learners since learners choose the teaching strategy that best suits their learning styles. 相似文献
8.
Steven J Lobritto Philip Rosenthal Rene Bouw Mimi Leung Paul Snell Richard D Mamelok 《Liver transplantation》2007,13(11):1570-1575
There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF required to provide a mycophenolic acid (MPA) exposure similar to that observed in adult liver transplant recipients receiving the recommended dose of MMF (target area under the plasma concentration-time curve from 0 to 12 hours [AUC(0-12)] for MPA of 29 mug.hour/mL in the immediate posttransplantation period and 58 microg x hour/mL after 6 months). A 12-hour pharmacokinetic profile was collected for 8 pediatric patients (mean age 20.9 months) on stable doses of MMF and CsA who had received a liver transplant > or = 6 months prior to entry and who had started on MMF within 2 weeks of transplantation. Mean MMF dosage was 285 mg/m(2) (range, 200-424 mg/m(2)). Of 8 patients, 7 had a MPA AUC(0-12) (range, 11.0-37.2 microg x hour/mL) well below the target. One patient had an AUC(0-12) > or = 58 microg x hour/mL but was considered an outlier and was excluded from analyses. Mean MPA AUC(0-12) and maximum plasma concentration values were 22.7 +/- 10.5 microg x hour/mL and 7.23 +/- 3.27 microg/mL, respectively; values normalized to 600 mg/m(2) (the approved pediatric dose in renal transplantation) were 47.0 +/- 21.8 microg x hour/mL and 14.5 +/- 4.21 microg/mL. In conclusion, assuming that MPA exhibits linear pharmacokinetics, when used in combination with CsA, a MMF dose of 740 mg/m(2) twice daily would be recommended in pediatric liver transplant recipients to achieve MPA exposures similar to those observed in adult liver transplant recipients. This finding should be confirmed by a prospective trial. 相似文献
9.
Dr. S. K. Rosenthal 《Archives of dermatological research》1930,162(1):95-101
Ohne ZusammenfassungMit 1 Textabbildung.Vorgetragen mit Demonstration von Kulturen in der dermatologischen Sektion der wissenschaftlichen medizinischen Association in Minsk am 5. I. 1930. 相似文献
10.
Terry Joe Sprinkle Julia F. Agee Russell B. Tippins C. Richard Chamberlain Guy B. Faguet George H. DeVries 《Brain research》1987,426(2):349-357
Monoclonal antibodies against human and bovine 2′:3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) were generated by fusing FOX-NY myeloma cells with spleen cells from RBF/Dn mice previously immunized with the purified brain antigens. The enzyme isolated from bovine brain was quite basic, with an isoelectric point of 9.71 and both the bovine and human enzymes consisted of a closely spaced doublet at approximately 44 and 46 kDa on SDS-PAGE. Six monoclonals were identified as strongly recognizing the enzyme on both ELISA plates and on immunoblots of whole brain protein. Four monoclonals very weakly cross-reacted with guinea pig myelin basic protein. In contrast with two previous reports, some of our monoclonal antibodies did immunostain 2 or 3 protein bands in peripheral nerve, two bands closely corresponding to those immunostained in central nervous system (CNS) myelin, the Wolfgram protein fraction and in acetone powders of whole brain. Each of the 6 monoclonals reacting strongly on immunoblots recognized the enzyme in from 2 to 5 of the species examined (human, bovine, rat, mouse and rabbit). In addition, all 6 monoclonals that immunostained the enzyme in whole brain, myelin and Wolfgram protein immunoblots recognized both CNP1 (44 kDa) and CNP2 (46 kDa). The two closely spaced protein bands observed on SDS-PAGE and previously stained on immunoblots of CNS CNPase using polyvalent rabbit anti-bovine CNPase antisera, and now different monoclonal antibodies, appear to be immunologically related and to contain highly conserved sequences. 相似文献